In this study, we primarily confirmed that the expression level of ZFP57 was down-regulated in both breast cancer tissue samples and cell lines compared to adjacent normal tissues and nontumorigenic HBL-100 cells, which is consistent with the TCGA database. This evidence concerns the gene ZFP57 and breast cancer.